T Cell Interstitial Migration: Motility Cues from the Inflamed Tissue for Micro- and Macro-Positioning by Alison Gaylo et al.
October 2016 | Volume 7 | Article 4281
Review
published: 14 October 2016
doi: 10.3389/fimmu.2016.00428
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Wolfgang Weninger, 
The Centenary Institute, Australia
Reviewed by: 
Anna Fogdell-Hahn, 
Karolinska Institutet, Sweden 
Emma Harriet Wilson, 
University of California Riverside, 
USA
*Correspondence:
Deborah J. Fowell  
deborah_fowell@urmc.rochester.edu
†Alison Gaylo and Dillon C. Schrock 
contributed equally to this work.
Specialty section: 
This article was submitted 
to Multiple Sclerosis and 
Neuroimmunology, a section of the 






Fernandes NRJ and Fowell DJ (2016) 
T Cell Interstitial Migration: Motility 
Cues from the Inflamed Tissue for 
Micro- and Macro-Positioning. 
Front. Immunol. 7:428. 
doi: 10.3389/fimmu.2016.00428
T Cell interstitial Migration: Motility 
Cues from the inflamed Tissue for 
Micro- and Macro-Positioning
Alison Gaylo†, Dillon C. Schrock†, Ninoshka R. J. Fernandes and Deborah J. Fowell*
Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, Aab Institute of 
Biomedical Sciences, University of Rochester, Rochester, NY, USA
Effector T cells exit the inflamed vasculature into an environment shaped by tissue-specific  
structural configurations and inflammation-imposed extrinsic modifications. Once within 
interstitial spaces of non-lymphoid tissues, T cells migrate in an apparent random, 
non-directional, fashion. Efficient T cell scanning of the tissue environment is essential 
for successful location of infected target cells or encounter with antigen-presenting cells 
that activate the T cell’s antimicrobial effector functions. The mechanisms of interstitial 
T cell motility and the environmental cues that may promote or hinder efficient tissue 
scanning are poorly understood. The extracellular matrix (ECM) appears to play an 
important scaffolding role in guidance of T cell migration and likely provides a platform 
for the display of chemotactic factors that may help to direct the positioning of T cells. 
Here, we discuss how intravital imaging has provided insight into the motility patterns 
and cellular machinery that facilitates T cell interstitial migration and the critical environ-
mental factors that may optimize the efficiency of effector T cell scanning of the inflamed 
tissue. Specifically, we highlight the local micro-positioning cues T cells encounter as 
they migrate within inflamed tissues, from surrounding ECM and signaling molecules, as 
well as a requirement for appropriate long-range macro-positioning within distinct tissue 
compartments or at discrete foci of infection or tissue damage. The central nervous 
system (CNS) responds to injury and infection by extensively remodeling the ECM and 
with the de novo generation of a fibroblastic reticular network that likely influences T cell 
motility. We examine how inflammation-induced changes to the CNS landscape may 
regulate T cell tissue exploration and modulate function.
Keywords: T cell, motility, migration, inflammation, chemokines, extracellular matrix proteins, CNS, multiphoton 
imaging
iNTRODUCTiON
The immune system’s success relies on its ability to survey and rapidly respond to infection or damage 
throughout the body. This task depends on the efficient movement of leukocytes within and between 
diverse tissues. In recent years, the ability to visualize this dynamic migration using intravital 
imaging has led to new insights into the cellular interactions between leukocytes and the tissue 
stroma, T cell “search” patterns within inflamed tissues and the molecular mechanisms that control 
leukocyte motility and positioning (1). Innate and adaptive immune cells have distinct functional 
roles as part of a coordinated immune response and must move within complex tissues that are often 
extensively remodeled by inflammation. Therefore, it is not surprising that mechanisms of motility 
FigURe 1 | environmental modulators of T cell interstitial migration. T cells enter inflamed sites and must scan the interstitial tissue to locate areas of tissue 
damage or infection. Their efficiency of interstitial migration is influenced by: (1) the physical structure, level of confinement, and stiffness of ECM; (2) composition of 
the ECM, collagen fiber-associated matrix proteins, such as fibronectin; (3) cellular composition of the tissue providing: a cellular surface for traction, a source of 
chemotactic signal, steric hindrance, and a cellular host for pathogens that manipulate the immediate microenvironment; and (4) chemokinetic or chemotactic 
factors, associated with the ECM, or as a soluble gradient, or within cellular membrane fragments.
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differ between immune cell types and differ for a given cell type 
depending on the context-dependent array of environmental 
cues it encounters. Here, we focus on T cell interstitial motility 
but take our “cues” from elegant studies on dendritic cell (DC) 
and neutrophil motility dynamics. How leukocytes integrate and 
interpret the cacophony of signals coming from their tissue locale 
into “go” signals during migration and “stop” signals for cell–cell 
interactions is yet to be fully understood (Figure 1). T cells must 
traverse their immediate tissue terrain (micro-positioning) as well 
as accumulate at specific focal sites of infection or damage within 
inflamed tissues (macro-positioning). Determining whether the 
cues for these related actions are shared or distinct will be critical 
to fully understand in situ T cell function.
The T cell response is initiated in lymph nodes (LNs) that drain 
sites of infection or inflammation. T cells are activated by antigen-
presenting cells (APCs), mainly DCs, that have migrated from the 
infected tissue carrying pathogen-derived products presented as 
peptides in the context cell surface MHC molecules. The APCs 
also convey information on the type of pathogen or inflamma-
tion that they have encountered in peripheral tissues. Through 
the secretion of specific cytokines, DCs drive the differentiation 
of T cells into functionally distinct effector cells (Th1, Th2, and 
Th17) that are better equipped to clear specific pathogens (2, 3). 
Effector T cells also exit the LN better prepared to interact with the 
inflamed vasculature through upregulation of adhesion molecules 
and chemokine receptors (3). As reviewed elsewhere (4, 5), there 
is now a well-defined series of steps for leukocyte extravasation, 
the spatiotemporal kinetics of which have been greatly aided by 
dynamic intravital confocal and multiphoton microscopy. Once 
T cells cross the vascular and basement membrane barriers, they 
are met with an often chaotically organized inflamed interstitium. 
Effector T cells must scan and localize to the area of infection or 
damage to exert their effector function. Although LN-instructed 
tissue-specific homing cues provide some preprogramed localiza-
tion bias (6–9), the inflamed endothelium appears to promote the 
non-selective entry of a host of different effector T cells. These 
effector T cells enter an inflammatory landscape unlike any tis-
sue structure they have previously encountered and must utilize 
cell-intrinsic motility machinery and environment-specific cues 
to “explore” the new space. We know little about this process for 
T cells, but studies on innate immune cell types have revealed 
remarkably adaptable and coordinated mechanisms that prompt 
movement within inflamed tissues. DCs have been shown to be 
extraordinarily adept in their ability to seamlessly adapt to differ-
ent adhesive substrates for locomotion enabling them to traverse 
a variety of inflamed microenvironments (10). For neutrophils, 
interstitial migration is aided by cell–cell communication, in 
part by neutrophil-release of leukotriene B4 (11) that facilitates 
collective streaming or swarming of neutrophils to a focal point 
of tissue damage. How effector T cells navigate through heteroge-
neous inflamed landscapes is less well-defined, yet, it is a critical 
final step in pathogen clearance and tissue repair.
IN SITU ANALYSiS
The mechanics of leukocyte locomotion have largely been defined 
using in vitro models of 2D and 3D environments, most notably 
collagen and fibrinogen gels and microchannels. These studies 
have created basic paradigms for amoeboid versus mesenchymal 
motility, adhesive versus non-adhesive motility (12, 13), the 
impact of physical confinement (14), and the response to soluble 
and immobilized chemokines (15). While useful for defining pos-
sible molecular requirements, such engineered 3D matrices fail to 
reflect the in vivo composition of the extracellular matrix (ECM), 
the combinatorial array of chemokinetic and chemotactic signals 
or the cellular diversity in a given tissue. Importantly, the in vitro 
models do not address the impact of inflammation on such tissue 
complexity. Indeed, this fundamental difference was highlighted 
in our recent intravital multiphoton studies of Th1 interstitial 
motility in the microbially inflamed dermis (16). It is widely 
TAbLe 1 | Novel insights into leukocyte function from intravital imaging.
Discovery Reference
Naïve T cell:APC dynamics. First look at the initiating events in 
T cell activation showing distinct phases of short and longer 
interactions
(127)
Stromal cell networks guiding T cell LN migration. Evidence that 
T cells utilized the fibroblastic reticular network for movement 
within the LN
(34)
T:B cell dynamics at the T/B border. Motile T:B conjugates led by 
the B cells and controlled by T cell SAP
(128, 129)
Lévy walks for CD8 T cells. Dynamic imaging revealed that T cells 
migrate in a random walk pattern that may enhance search 
capacity for rare targets
(45)
Neutrophil swarming. Evidence that neutrophils communicate 
via an intercellular relay mechanism for long-range directional 
guidance
(11)
Lymphocyte trafficking between B cell follicles. Demonstrated 
that TFH cells move between multiple germinal centers, potentially 
enhancing the antibody repertoire
(27)
Intravascular leukocyte function. Neutrophils and CD8 T cells can 
perform antimicrobial functions without leaving the vasculature
(89, 130)
Chemokines in T:APC interactions. CD8 T cells required 
expression of CXCR3 to efficiently contact and kill virally infected 
cells in the skin
(69)
Neutrophil trails. Neutrophils deposit chemokine-rich membrane 
fragments that enhance CD8 cell accumulation in the  
influenza-infected lung
(102)
CTL:target cell dynamics. Revealing motile kinases with 
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thought that leukocyte interstitial motility in 3D environments 
is not dependent on integrin-based adhesive locomotion (12, 
17–19). This notion has been supported by a number of compre-
hensive in vivo studies demonstrating that motility of DCs and 
neutrophils in the skin (steady state or acute injury), and T cells 
in the LN, can indeed be integrin-independent events (11, 20, 21). 
In contrast, we found that Th1 cell motility closely followed the 
ECM fibers in the inflamed dermis and was dependent on T cell 
expression of the matrix-binding integrin αV (in combination 
with β1 and/or β3). The discrepancy between in vitro and in vivo 
studies over the need for integrin-based motility likely reflects 
the impact of inflammation on tissue remodeling. Adjuvant-
induced inflammation in the skin led to a change in the density 
of the collagen fibers in the dermis, in the deposition of the ECM 
components, and in the recruitment of innate cell types. Thus, 
the changes in the tissue landscape in vivo during inflammation 
are complex and multifactorial, and quite distinct from the 
simplified artificial matrices used in in vitro studies. Identifying 
distinct environmental components, which dictate a dependency 
on specific molecular machinery for motility in the context of 
such complexity will be important. With the growing number of 
intravital studies in inflamed and infected tissues, it is likely that 
we will continue to see challenges to the current concepts of 3D 
interstitial migration.
Intravital microscopy has proven a powerful tool for the 
dissection of spatiotemporal behaviors of leukocytes in  situ. 
Numerous observations in the past 15  years have led to novel 
insights into immune function that had not been predicted 
from conventional static measures (Table  1). Yet, there are 
limitations to our current intravital investigative abilities in vivo. 
Multiphoton (two and three photon) microscopy has provided 
the depth resolution to begin to examine tissues in situ. However, 
these studies are only as good as the structures or cells that can 
be illuminated with fluorescent probes or with optical effects such 
as second-harmonic generation (SHG) or use of endogenous tis-
sue fluorescence [elastin, keratin, FAD, and NAD(P)H] (22, 23). 
Multiphoton constraints come from single or dual laser systems 
that limit the number of fluorophores that can be simultaneously 
excited, thus, restricting the complexity of structures and cells 
that can be visualized in a given field at the same time. In addi-
tion, with respect to the ECM, there is limited capacity to label 
these moieties in real time. Current approaches heavily rely on 
intravital multiphoton detection of fibrillar collagen with SHG, 
but this is likely only to reveal a skeleton of the ECM. Fixed tissue 
immune-histochemical techniques have revealed that these col-
lagen structures are often enveloped by other matrix components, 
such as fibronectin and lipid moieties, which are optically silent 
in current multiphoton studies (16, 24, 25). In the brain, defining 
the ECM structure in real time is particularly challenging as the 
ECM structure is often non-fibrillar and hence not visualized by 
SHG. Thus, dynamic imaging of leukocytes is only as good as 
the ability to define the optically dark “black” space surrounding 
the cells of interest (Figure 2). The actual matrix and/or cellular 
structures over or between which T cells move in the inflamed 
interstitium remain poorly defined. The ultimate goal will be to 
generate a topographical map of the inflamed tissue to assess the 
structural, chemical, and cellular contributions that act to guide 
interstitial T cell scanning and positioning. Moreover, while we 
can intensely interrogate the micro-positioning cues measured 
over short distances (200–500 μm) for short periods of time 2–3 h, 
intravital dissection of the macro-positioning (400–800  mm) 
that likely takes place over a much longer timeframe (8–12 h) is 
challenging. Additionally, while multiphoton imaging allows for 
visualization of structures and cells deeper within tissues than 
confocal or epifluorescent imaging modalities, the resolution of 
multiphoton imaging is limited by long excitation wavelengths 
and asymmetric distortion of laser pulses, compromising intra-
vital motility analyses such as the intracellular redistribution 
of molecules during migration and cell–cell interactions (26). 
Recent advances that combine photoactivation or photoconver-
sion systems with multiphoton imaging will allow for pinpoint 
fluorescent labeling of a given cell or groups of cells in a given 
location in a tissue for assessment of long-range spatiotemporal 
dynamics, as recently shown for lymphocyte exchange between B 
cell follicles in the LN (27).
LeSSONS FROM LYMPHOiD TiSSUeS
Before entering inflamed tissues, T cells have undergone a 
series of activation events in the LN that has armed them with 
discrete functional properties and the ability to better respond 
to environmental cues that may be encountered in inflamed tis-
sues. The spatial positioning of T cells within the LN for optimal 
T cell activation and differentiation has been extensively reviewed 
FigURe 2 | intravital multiphoton imaging and its limitations. (A) Motility patterns of effector CD4 T cells in the inflamed dermis showing micro-positional 
shape changes consistent with dynamic information sampling. (b) Imaging capabilities and limitations. Current intravital multiphoton analysis utilizes the SHG signal 
to highlight the fibrillar core of the tissue matrix and the association of migrating T cells with this structure (a). However, the fibrillar core is cloaked in numerous ECM 
proteins that cannot, at present, be visualized in real time (b). Moreover, the directional decision making is influenced by chemical signals presented on the ECM, 
these factors are also optically silent in current real time imaging (c). An additional layer of complexity is provided by the host of stromal and immune cells that are 
present in the inflamed tissue (d). Our current multiphoton capacity may allow for the detection of the SHG signal in combination with analysis of the interaction 
between two (may be three) additional fluorescently tagged cell types. But the ability to visualize the quality of these interactions through probes that illuminate 
signaling events is limited both in optically separable colors and in resolution.
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elsewhere (3, 28–30) and is not the focus of this current review. 
However, there are a number of mechanistic concepts that have 
arisen from the study of interstitial migration of T cells within 
the LNs that are worth noting here as reference points for our 
discussion of T cell movement in inflamed non-lymphoid tissues. 
First, T cells must engage with particular DCs in order to receive 
activation signals for function. DCs present a variety of peptides 
in the context of MHC molecules on their cell surface and DCs 
presenting a given peptide are likely at low frequency, estimated at 
1:100 (31). Thus, each antigen-specific T cell needs to scan the cell 
surface of many DCs before encountering one that is presenting 
their specific antigen. Whether this is an active “search” or an 
optimized chance encounter is unclear (32). Second, intravital 
imaging of the LN has shown that T cell amoeboid-like motility 
best fits a random walk with no evidence of directional migra-
tion over a 400–600 μm span (33). The shaping of such motility 
patterns to optimize scanning of the LN is likely to be influenced 
by both T cell intrinsic migratory machinery and extrinsic 
directional cues. Third, the structural organization of the LN 
provides a scaffold for T cell migration that optimizes encounters 
with DCs. The highly organized fibroblastic reticular cell net-
work (34) acts as a cellular platform for chemokine-dependent, 
integrin-independent, haptokinetic T cell movement and also 
promotes encounter with DCs by colocalizing T cells with DCs 
(35). Fourth, T cell effector functions are acquired and refined 
in spatially distinct locations requiring repositioning within the 
LN. In recent years, our understanding of the signals for T cell 
activation and differentiation has been reshaped to incorporate 
location-specific instructional cues. Differentiation of both Th1 
and Th2 cells in the LN is not complete without the relocation of 
activated T cells from the T cell zone to spatially distinct regions, 
namely the peri and interfollicular regions (36, 37). APCs in those 
specific regions provide additional differentiation signals to T 
cells to complete functional maturation. Chemokine production 
by the APCs and corresponding chemokine receptor expression 
by the T cells both appear key to such T cell positioning (28). How 
these apparent long-range positioning cues relate to the cues for 
the observed random walk of T cells still needs to be reconciled. 
FigURe 3 | Micro- and macro-positioning cues. (A) Micro-positioning 
cues for short-range cell directionality and motility patterns. T cell motility and 
scanning patterns are influenced by the microanatomical physical and 
chemical structure of the inflamed tissue. (i) The ECM could provide physical 
barriers to forward movement in one direction necessitating a change in 
direction toward a more accessible area. Cells are often seen doubling back 
on their path at points where the tissue may be impassable. (ii) ECM 
components may also positively guide directionality as an adhesive substrate 
that may provide footholds for T cell movement. (iii) Chemotactic cues, such 
as cytokines, are often presented on the ECM and could dictate scanning 
patterns and directionality. That T cells often backtrack suggests chemokines 
may provide a chemokinetic signal in the absence of a directional cue. 
(iv) The cellular make up of a T cell’s immediate surroundings could influence 
directionality through steric hindrance or by facilitating migrational paths 
along cellular projections closely associated with the ECM. (b) Macro-
positioning cues for long-range movement between distinct regions of a 
tissue. (i) The mechanistic basis for cellular positioning within a tissue is 
poorly understood in real time but is controlled in part by distinct expression 
of adhesion receptors and ligands on individual cell types and at distinct 
anatomical locations. (ii) Chemokines are also critical regulators of 
positioning; achieved by active chemotaxis to immobilized, or soluble 
diffusive gradients, or by self-generated chemotactic gradients. 
(iii) Alternatively, chemokines can induce cellular arrest or retention to 
effectively halt T cells in areas of high or uniform chemoattractants such as 
infection foci. (iv) Not touched on in this review, but important for future study, 
pathogens often manipulate these chemoattractant signals through decoy 
receptors or soluble factors that inhibit or disrupt local directional cues for 
T cell positioning.
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The upregulation of specific chemokine receptors may make 
activated T cells more receptive to APC-derived chemotactic 
cues, but direct evidence of T cell directional migration in the 
LN toward the interfollicular region is lacking. If not actively fol-
lowing a chemotactic gradient, it is possible that the chemokine-
driven positioning cues may instead act as focal arrest signals for 
randomly migrating T cells (38). Thus, observations from the LN 
have highlighted the importance of efficient T cell scanning of 
tissues, the interface between T cells and the tissue structure, and 
how tissue location can impact function: all important concepts 
when considering effector T cell motility in non-lymphoid tissues.
MiCRO- AND MACRO-POSiTiONiNg  
iN iNFLAMeD TiSSUeS
The movement of effector T cells within inflamed tissues is critical 
for their ability to function in the control of infection and in tissue 
repair. As in the LN, T cells entering the inflamed tissue require 
encounter with APCs expressing their cognate ligand. The effi-
ciency of APC encounter will depend on a balance between being 
able to scan a large enough area of the tissue and scanning any 
given area with sufficient rigor (32, 39, 40). Unlike the LN, most 
inflamed non-lymphoid tissues do not appear to have an organ-
ized fibroblastic reticular cell network that could help to direct T 
cell scanning along structures that are also sites of APC localiza-
tion. One might imagine that the infected tissue may require less 
organizational help to facilitate T:APC encounters because the 
frequency of both antigen-specific T cells and APCs bearing cog-
nate antigen are enriched at the infection site in comparison to the 
LN. However, intravital studies in mycobacterial granulomas of 
the infected liver revealed that antigen presentation was surpris-
ingly limiting (41). Antigen-specific T cells in the infected liver 
showed few episodes of arrest, often used as a surrogate for T:APC 
interactions, corresponding to poor T cell activation and limited 
IFNγ effector function (41). Thus, there is both a conceptual and 
practical advantage to defining the signals that optimize T:APC 
encounters in inflamed tissues to enhance effector function and 
promote pathogen clearance. With respect to pathogen clear-
ance, certain T cell cytokines have a limited range of biological 
activity, hence interstitial motility must also promote the correct 
cellular positioning relative to a region of focal infection. In the 
Leishmania major model of cutaneous infection, it was estimated 
that CD4 T cell production of IFNγ had an 80-micron effective 
range, measured by the ability of secreted IFNγ to activate nitric 
oxide pathways in macrophages surrounding the site of T cell 
activation (42). We suggest that the signals and mechanisms of 
motility employed for micro-positioning that regulate local T cell 
maneuvering of the tissue terrain on a micrometer scale may be 
distinct from the motility that accounts for macro-positioning 
of T cells at focal points of infection or damage on a millimeter 
scale (Figure 3).
Motility Patterns
In lieu of the current ability to visualize the topography of the 
infected tissues, researchers have initially focused on defining 
the patterns of T cell interstitial motility and the basic molecular 
machinery required for locomotion in inflamed tissues (17, 19, 
32, 43). In a variety of tissue locations (skin, brain, liver, and gut), 
and under distinct inflammatory challenges, T cell interstitial 
motility is amoeboid-like in nature (18) (Figure  2A) and has 
been likened to a non-directional, random walk (33, 44). Unlike 
many innate immune cells, there is no requirement for proteolytic 
cleavage of tissue matrix for motility and no evidence of T:T cell 
communication for streaming or collective migration. A more 
detailed analysis of the type of random walk for CD8 T cells in the 
Toxoplasma gondii-infected brain revealed a pattern of random 
motility that most closely resembled the generalized Lévy walk 
(45) with a number of small steps for intense exploration of an 
area interspersed by random longer steps for a wider search area. 
6Gaylo et al. T Cell Interstitial Migration
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This pattern is observed across species from sharks to honeybees 
in the search for rare resources. Indeed, modeling of this T cell 
behavior revealed that the Lévy walk was more efficient in find-
ing rare APC targets than the random Brownian walk (39, 45). 
Whether this type of tissue scanning is generalizable to other T 
cell subsets and to CD8 T cells in different locations is not yet 
known. However, the observation has sparked much interest in 
examining the potential link between the T cell “search” for rare 
APC targets in inflamed sites to models of search theory (32). 
While the use of “search” evokes a desire or need that probably 
does not equate to T cell scanning of inflamed tissues for APC, 
such conceptual parallels are likely to provide interesting hypoth-
eses for future studies.
Mechanisms of Motility
The movement displayed by effector T cells in lymphoid and non-
lymphoid tissues morphologically resembles that of amoeboid 
migration with cells constantly changing shape with protruding 
and retracting pseudopods (Figure 2A). Amoeboid migration is 
driven by the forces generated by polymerization of the actomyosin 
cytoskeleton and, in its basic form, depends on polymerization of 
actin for protrusions and type II myosin-dependent actomyosin 
activity for contraction (17, 18, 46, 47). These forces need traction 
created by an interacting surface to drive locomotion. Migration 
on 2D surfaces, such as the vascular endothelium, during extrava-
sation, requires adhesion for traction (48). Integrins are critical 
for this adhesion step and are dynamically activated at the leading 
edge via inside-out signaling from GCPRs or outside-in signaling 
in the presence of high substrate availability (49). Regulation of 
integrin de-adhesion at the trailing edge of the cells via myosin 
II-dependent contraction detaches the cell from its substrate 
allowing for forward migration (50). In 3D environments, the 
need for surface adhesion for motility is mitigated by the ability 
to use opposing surfaces of the tissue matrix for traction in an 
integrin-independent fashion (14, 51, 52). Leukocytes are thought 
to use the matrix as a physical scaffold for pushing mediated by 
actin polymerization at the leading edge and myosin-dependent 
squeezing at the rear. This non-adhesive locomotion is dependent 
on the degree of physical confinement afforded by the density 
of the surrounding tissue matrix (10, 14, 53, 54). As previously 
mentioned, these lines of distinction between 2D high adhesion 
and 3D low adhesion modes of motility appear to become blurred 
in the context of inflammation, with effector CD4+ T cell intersti-
tial motility being dependent on the matrix-binding αV integrins 
(16). Integrin-dependency for interstitial migration occurred 
within the context of a tissue matrix that had been modified 
by inflammation. The inflamed dermis was associated with the 
fibrillar collagen scaffold (as defined by SHG) becoming less 
dense than the non-inflamed dermis. One possibility, therefore, 
is that the change in the matrix density limits the efficiency of 
a purely biophysical mechanism of force transduction and leads 
to T cell dependency on integrins for traction. At this stage, it 
is not clear if the mechanism of T cell interstitial motility has 
any effect on the efficiency of tissue scanning for cognate antigen. 
Interestingly, adhesion-based motility has long been thought to 
be a slower process than non-adhesive amoeboid movement (17, 
54). Integrin-based interstitial migration may, therefore, afford 
the effector T cells, a more thorough scan of the local inflamed 
microenvironment and may enhance interactions with haptotac-
tic signals.
intrinsic Programing for T Cell  
interstitial Motility
How micro-positioning decisions are made by T cells as they scan 
the inflamed tissue (Figure 2A) is unresolved. However, T cells 
are likely to be guided by their immediate physical and chemical 
milieu as discussed in the next section. Given, how fundamental 
the ability to move through inflamed tissues is to T cell function, 
it has been suggested that T cells may have specific cell-intrinsic 
mechanisms to optimize interstitial motility. The first demonstra-
tion in support of this notion came from the study of a hematopoi-
etic cell-specific myosin, Myosin 1g (Myo1g) (55). T cells express 
high levels of Myo1g, and it appears to be dynamically relocated 
at the plasma membrane particularly during migration in 3D 
environments. In the absence of Myo1g, T cell 3D migration pat-
terns were altered with increased speed and straightness. Using 
in silico modeling alongside in vivo imaging, the altered migration 
pattern in the absence of Myo1g was shown to reduce the capacity 
of T cells to search for rare APC targets. Thus, through expression 
of Myo1g, T cells appear to be inherently prepared for efficient 
scanning of 3D tissues. In addition to a pre-tuned program for 
T cell motility, T cells may also acquire new interstitial migra-
tory potential during their activation and differentiation in the 
LN. Studies on the importance of integrin αV for Th1 interstitial 
motility in the inflamed dermis showed that αV expression is 
specifically upregulated on those activated T cells destined to exit 
the LN for effector function in peripheral tissues (16) and also 
enhanced in Th17 cells in the CNS (56). Therefore, the activation 
and differentiation process in the LN appears to prepare effector 
T cells for more efficient interactions with the inflamed matrix for 
interstitial motility. Distinct cytokine-producing T cell subsets 
such as Th1, Th2, and Th17 cells most likely need to function in 
very different inflammatory milieus that are shaped by distinct 
pathogen challenges. It will be interesting to determine if these 
cells may be distinctly programed during differentiation to 
express a unique motility toolbox tailored to efficient interstitial 
motility in specific inflammatory environments.
T cell-intrinsic programing for macro-positioning within 
a tissue is evident on numerous levels. In response to herpes 
simplex virus, CD4 and CD8 effector T cells both efficiently enter 
the infected dermis but locate to distinct regions of the skin: CD4 
T cells to the dermis and CD8 T cells to the epidermis (57). Similar 
differences in the position of CD4 and CD8 T cells have been seen 
at other mucosal sites (57–60). Distinct macro-positioning in the 
skin was not due to differences in interstitial motility patterns 
between the two T cell subsets but correlated with CD8 T cell 
expression of the integrin αE (CD103) and epithelial expression 
of its ligand E-cadherin (57). It is not clear if there is differential T 
cell directional guidance to the epidermis, or if these interactions 
simply provide important stop signals for retention in the distinct 
areas. Similar questions arise when considering the programing 
differences in chemokine receptor expression between CD4 T 
effector cell subsets. Functionally distinct Th1, Th2, and Th17 
7Gaylo et al. T Cell Interstitial Migration
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subsets express overlapping, yet, distinct arrays of chemokine 
receptors that are induced during differentiation (61). The par-
ticular chemokine receptors expressed appear to provide unique 
recruitment and positioning advantages to each subset. Best 
studied, thus far, is the expression of CXCR3 (ligands, CXCL9, 
CXCL10, and CXCL11) by Th1 and CD8 cells. CXCR3 is not 
expressed by Th2 cells and is variably expressed by Th17 cells. 
CXCR3 has been implicated in CD4 T cell localization to the 
interfollicular region in the LN to complete Th1 differentiation 
(36), Th1, and CD8 entry into numerous infected tissues and 
tumors (62–68) and more recently in the ability of CD8 cytotoxic 
T cells to locate and kill virally infected cells within the infected 
skin (69). CXCR3-deficient CD8 T cells were able to enter the 
vaccinia virus-infected dermis, but fewer CD8 T cells entered, 
or were retained in, the infection foci compared to WT CD8 T 
cells (69). Interestingly, of the CD8 T cells that made it into the 
virus-infected foci, CXCR3-deficient CD8 T cells moved more 
quickly than CXCR3-expressing CD8 T cells suggesting that 
CXCR3 facilitates T:APC interactions by decreasing the speed 
or inducing arrest of the effector T cells. Indeed, elegant studies 
in zebrafish have revealed that neutrophil motility is restricted 
in the immediate vicinity of a cellular chemokine source sug-
gesting that, at high or uniform concentrations, chemokines can 
optimize retention at specific sites in the infected tissue (38). 
Differential chemokine receptor expression on Th1 (CXCR3+) 
and Th17 (CCR6+) cells also appears to play a role in autoreac-
tive T cell accumulation in discrete regions of the central nervous 
system (CNS) resulting in quite different pathological disease 
(see section below). As will be discussed below, it is unclear 
if the expression of these chemokine receptors guide micro-
positioning during interstitial motility of T cells, or if the macro-
positioning of these distinct T cells is guided by focal chemokine 
gradients or retention signals (Figure  3). Nonetheless, T cell 
subset-specific chemokine receptor expression appears critical 
for macro-positioning within the LN and at sites of infection or 
inflammation. Thus, cell-intrinsic motility programs acquired by 
effector T cells during activation in the LN equip T cells with the 
potential to respond and adapt to a variety of environmental cues 
that may be present in the inflamed target tissue. The utilization 
of particular motility components within inflamed tissues will 
be driven by the type of inflammatory-induced changes within 
the target tissue.
eNviRONMeNTAL CUeS
Effector T cells entering an inflamed tissue are met by a cloud of 
environmental cues from the ECM, lipid moieties, chemokines, 
cytokines, and purinergic factors, among others. How the T cell 
integrates and weighs the importance of the different signals for 
interstitial motility is not clear. On the micro-positioning level, 
the rapid cell shape changes during effector T cell interstitial 
motility (Figure 2A) suggest constant information sampling for 
directional decision-making. There is fairly sparse in vivo data 
on the environmental cues that actually support the motility 
patterns observed for T cell migration in 3D, hindered in part 
by the difficulties in visualizing, in real time, the matrix struc-
ture and associated chemotactic factors. An emerging theme, 
however, is that T cells utilize the tissue structure as a scaffold 
for haptotaxic motility.
Physical guidance Cues
The ECM defines the 3D structure of tissues; the organization 
and composition of which is distinct for individual tissues in 
the steady state. During inflammation, the ECM is extensively 
remodeled through the release of cytokines and matrix metal-
loproteinases, changing the biophysical structure of the matrix, 
its composition and its “presentation” of bioactive compounds 
that impact leukocyte motility and function (70–72). The inter-
stitial matrix of many tissues is made up of a core collagen fiber 
network, the topography of which is shaped by its associating 
glycoproteins, such as fibronectin, and proteoglycans, such as 
decorin and versican, that contain glycosaminoglycans (GAGs) 
subunits. GAGs play important roles in sequestration and display 
of chemokines and cytokines (73–75). Leukocytes interact with 
the ECM and can process signals from the physical spacing and 
composition of the fibers, the rigidity of the matrix (mechano-
sensing), and immobilized chemical signaling moieties (76, 77). 
In turn, these signaling events direct leukocyte migration, func-
tion, and survival.
Intravital imaging in different tissues has shown that T cell 
motility closely follows a network of fibrillar structures defined 
by SHG (16, 78–80). As discussed for actomyosin motility, the 
density of the ECM is likely to dictate the effective molecular 
machinery that will facilitate T cell movement. Three-dimensional 
confinement studies using microchannels revealed a change in 
the CD8 T cell migration efficiency based solely on the spacing 
between fibronectin-coated surfaces, with T cell MyoIIA opti-
mizing T cell motility by limiting surface adhesion (14). In vivo, 
within a given inflamed tissue, T cells are likely to experience a 
highly heterogeneous physical structure with variable degrees of 
confinement. Some have suggested that T cells may adapt to these 
changes by following paths of least resistance (17), while studies 
from DCs and neutrophils suggest that leukocytes can rapidly 
adapt to distinct terrains by switching between adhesive and 
non-adhesive motility (10, 11). The impact of utilizing possible 
“preferred” paths through a tissue, versus the ability to switch 
between migration modes, on the efficiency of T cell scanning 
of a tissue for APC encounter has yet to be determined. To add 
to the complexity, the actual physical space that T cells navigate 
within will also be shaped by the cellular composition of the 
tissue (Figure  2B), thus the true degree of T cell confinement 
in vivo is difficult to predict. In the LN, T cells can migrate along 
the cellular FRC network, where fibroblasts envelop a collagen 
core. In non-lymphoid tissues, both fibroblasts and macrophages 
can extend long cellular protrusions that align along the colla-
gen fibers and could also provide a cellular platform for T cell 
migration. Indeed, macrophage aggregates in liver mycobacterial 
granulomas appear to provide a cellular scaffold for effector T cell 
migration (81). The extent to which T cells interact directly with 
the ECM versus indirectly via ECM-associated cells is likely to be 
context-dependent.
In addition to changes to the structure of the interstitial matrix, 
inflammation and tissue damage have a dramatic impact on the 
composition of the ECM, with collagen fibers being decorated 
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with fibronectin, vitronectin, and tenascin. The magnitude and 
patterning of ECM deposition likely plays a role in both T cell 
micro- and macro-positioning (Figure  3). In contexts where 
matrix-binding integrins facilitate T cell interstitial motility, the 
microanatomical display of the matrix ligands may guide T cell 
motility patterns by providing local “footholds” or may vary the 
efficiency of scanning by impacting the speed of T cell movement 
due to variation in traction. Effector T cells express a variety of 
matrix-binding integrins that provide ligand specificity for 
distinct matrix components (49, 82–84). The relative expression 
of particular matrix-binding integrins differs between inflamed 
tissues. In the skin, CD4 effector T cells predominantly express 
α2β1 and αVβ1/β3, while in the lung and gut effector, T cells express 
a far wider variety of matrix-binding integrins (16). For skin and 
lung, the differences in integrin expression appear to correlate 
with the complexity of the matrix landscape. Inflammation in the 
skin led to a broad distribution of fibronectin across the dermis, 
while in the influenza-infected lung, there were spatially distinct 
regions that where either fibronectin-rich or collagen-rich (16). 
These compositionally distinct ECM regions within a tissue may 
afford distinct macro-positioning cues for local function or reten-
tion (3, 59, 85–88).
Our discussion has focused on the ECM as a physical facili-
tator of T cell interstitial migration. However, studies coming 
from the tumor field highlight the potential barrier function of 
a remodeled ECM. Real-time imaging of human lung tumor 
slices revealed that the density and orientation of the ECM fibers 
surrounding the tumor mass directed T cell migration around 
the tumor but restricted them from entering the tumor mass 
itself (80). Recent intravital imaging of CD8 T cells in the liver 
demonstrated the novel ability of CD8 T cells to sample the 
subsinusoidal hepatocytes and kill virus-infected hepatocytes, 
without exiting the vasculature (89), a function that was inhibited 
by changes to the liver structure during fibrosis. The degree to 
which the ECM imposes a physical restriction on T cell access 
during chronic infection and inflammation is unclear and war-
rants further investigation.
Chemical guidance Cues
Leukocytes can respond to multiple chemoattractants within the 
inflamed tissue including chemokines, cytokines, lipids, ECM 
fragments, and puronergic signals. For T cells, much of our 
understanding of chemotactic signals have come from the study 
of chemokines, chemokine-receptor expression, and the block-
ade of receptor signaling using GPCR inhibitors such as the Gi 
inhibitor, pertussis toxin. Interference at each of these levels has 
reinforced that chemokines are major positioning cues for T cells 
in the steady state and during infection and inflammation (35, 
61, 90, 91). While it has been assumed that diffusive chemokine 
gradients provide chemotactic cues for T  cell directed migra-
tion, direct evidence for chemokine gradients on a micro- or 
 macro-scale is limited (38, 92, 93). A subtle directional bias was 
observed for migration of CD8 T cells toward  HSV-1-infected 
cells in the skin, but cells moved away from the infection site 
almost as often as moving toward infected cells (94). The weak 
directional cues and the often observed patterns of random 
T cell motility using intravital imaging raise the possibility that 
chemokines direct T cell positioning in ways other than through 
classic concentration gradients (44).
For many chemokines, their activity is dependent on correct 
presentation by GAGs associated with the ECM or cell surfaces. 
While intravital studies utilizing pertussis toxin treatment have 
shown a dependency on Gi-linked signaling for interstitial 
migration, how the chemokines support T cell motility is unclear. 
Blockade of the CXCR3 ligand CXCL10 in the Toxoplasma-
infected brain reduced the velocity of CD8 T cells but did not 
disrupt the Lévy walk pattern of movement in the tissue (45). 
Thus, chemokines may not shape the pattern of T cell motility 
but, rather, optimize the speed of interstitial migration, which 
may in turn increase the rate of T:APC chance encounter. This 
could be achieved through a basic chemokinetic mechanism or 
through activation of matrix-binding integrins, akin to the well-
established role for chemokines in integrin activation and ligand 
binding on the vascular endothelium (95). More recently, an 
alternative mechanism has been proposed, that of self-generated 
chemotactic gradients (96). The model proposes that cells can 
form their own chemical gradient by degrading a local source 
of attractant. In vivo evidence for such a mechanism first came 
from studies of the migrating primordium of zebrafish where, 
in the presence of uniform expression of SDF-1, a signaling 
gradient across the primordium was achieved by sequestration 
of SDF-1 at the rear by the receptor CXCR7 (97, 98). Recent 
examples in the LN and spleen suggest that decoy receptors or 
metabolizing enzymes expressed by immune cells themselves 
remove or degrade the attractants to create local gradients for 
lymphoid migration (99–101). This potential mechanism may 
have distinct advantages for an effector T cell’s “search” of an 
infected/inflamed tissue as it can be effective over a wide range 
of attractant concentrations enabling long-range self-directed 
exploration. Moreover, by regulating the expression of distinct 
scavenging receptors, particular effector T cells may separate the 
functionally important signals from the multitude of chemotactic 
signals in an inflamed tissue.
A recent study of neutrophils in influenza-infected mice 
reveals an additional layer of T cell migratory control (102). 
Neutrophils crawling in the interstitium of the infected trachea 
left long-lasting membrane fragments behind that were enriched 
for the chemokine CXCL12. Such chemokine depots deposited 
by the neutrophils appeared to provide guidance cues for incom-
ing CD8 effector T cells for motility and effector function. These 
novel findings suggest that T cell interstitial migration may be 
shaped by the preceding recruitment and interstitial migration 
of innate cells that leave chemotactic trails for subsequent T cell 
movement.
The lack of evidence for macroscale directional migration 
leaves open the question of how chemokines guide cells to spe-
cific locations within a complex tissue. Common to many studies 
on T cell positioning is the presence of a location-specific cellular 
source of critical chemokines. Stromal cells in the interfollicular 
region of the LN were potent sources of CXCL9 required for 
Th1 intranodal repositioning during Th differentiation (36). 
Similarly, CXCL9 and CXCL10 were enriched in the vaccinia 
virus-infected cells in the skin and enhanced CD8 T cell posi-
tioning (69). As discussed in the context of CXCR3 expression, 
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these sources of high chemokine production may, instead of 
being chemotactic, provide signals for T cell arrest and/or 
retention (38). Indeed, the loss of CXCR3 expression on CD8 
T cells led to accelerated movement within the infection foci 
(69). Mechanistically, calcium signaling, possibly downstream 
of chemokine receptors, has been implicated in T cell arrest 
(103). High local concentrations of chemokines may addition-
ally enhance inside-out activation of matrix- or cell-binding 
integrins, mediating strong adhesion and arrest to cellular or 
ECM structures (95). Furthermore, chemokines, possibly via 
receptor mediated tethering, have also been shown to promote T 
cell activation upon APC encounter (104, 105); in effect doubling 
down on the “stop” signal by optimizing T cell signaling with 
cognate APCs.
In conclusion, the mechanisms that facilitate efficient T cell 
interstitial motility in inflamed tissues are, in part, shaped by 
initial activation and differentiation events in the LN draining 
the site of infection or damage. The implementation of specific 
migratory machinery at the site of inflammation, however, 
appears highly context-dependent. Efficient T cell scanning to 
locate infection or damaged foci is guided by the tissue-specific 
matrix scaffold and optimized, in terms of speed and positioning, 
by chemotactic and arrest/retention cues.
UNiQUe LANSCAPe OF THe CNS
The CNS is an immunologically unique tissue and thus presents 
a specific set of challenges and considerations for studying T cell 
motility and positioning. In the steady state, the composition of 
the CNS extracellular environment is distinct from most other 
peripheral tissues, lacking the collagen fiber networks that often 
impart tissue rigidity and organ-level organization. Instead, 
the interstitial ECM is composed principally of long hyaluro-
nan chains decorated with proteoglycans and cross-linked by 
tenascin-R (106). Along with this distinct interstitial ECM, the 
CNS is also punctuated with perineuronal nets. The perineuronal 
nets are distinct ECM structures composed of chondroitin sulfate 
proteoglycans that form dense structures around certain subsets 
of neurons and provide support and stability to neural connec-
tions (107). Together, the CNS ECM provides protection from 
mechanical stress while supporting the function of the neural 
network (106). Microglia, CNS-specific cells of the innate immune 
system, in conjunction with astrocytes, mediate tissue homeo-
stasis and are the first to respond to tissue damage or infection 
(108). Surveillance of the brain and spinal cord by T cells is rare 
but critical for control of chronic and latent infection (109). The 
importance of continual immune surveillance was highlighted 
following reactivation of latent JC polyomavirus infection and 
development of a progressive multifocal leukoencephalopathy 
after blockade of immune extravasation using the anti-α4 integ-
rin antibody Natalizumab (110). Those T cells that are present in 
the circulating cerebral spinal fluid under  homeostatic conditions 
are enriched for memory T cell markers and CXCR3 expression 
(111); however, a role for specific receptors in T cell immune 
surveillance of the CNS has not been defined. The atypical struc-
ture of the CNS parenchyma under homeostatic conditions may 
require distinct mechanisms of T cell interstitial motility from 
those utilized by T cells recruited to the CNS by inflammation 
and infection (112).
During inflammation, the CNS interstitial ECM as well as the 
perineuronal nets undergo substantial remodeling (113). Factors 
produced by infiltrating immune cells and resident glial cells drive 
this inflammatory restructuring. Enzymes degrade the HA-rich 
network, and the production of new ECM components by cells 
such as astrocytes changes the composition of the CNS ECM, alter-
ing its mechanical properties (106, 114). Inflammation-induced 
upregulation of fibronectin and fibrillar collagens have been 
shown to potentiate T cell migration in the CNS (115), although it 
is not known if this is an integrin-dependent process. Changes in 
the ECM also alter its interactions with other bioactive molecules 
such as chemokines and cytokines. For example, the proteoglycan 
decorin is strongly upregulated in CNS injury (116). In other tis-
sues, decorin has been shown to bind TGFβ and inhibit its func-
tion (117), while decorin binding to IFNγ or TNFα promotes their 
signaling capacity (118). Alterations in these particular cytokines 
could change leukocyte motility by modulating responses to 
chemokines and altering matrix metalloproteinase activity (119). 
New in vivo observations on the structural changes to the CNS 
during inflammation have important implications for T cell 
interstitial exploration and draw parallels to other  non-lymphoid 
and lymphoid tissues. Reports have documented the presence of 
reticular fiber-like structures that develop in the inflamed CNS. 
These structures, absent in the steady-state CNS, generate a SHG 
signal and are observed deep within the cortex, discrete from both 
the vasculature and the meninges (79, 120). While their molecular 
and cellular constituency remains unknown, the reticular fibers 
appear to provide a scaffold for T cell migration within the paren-
chyma. CD8 T cells were shown to traffic along these reticular 
fibers in a model of CNS infection with the protozoan parasite 
Toxoplasma gondii (79). Immunohistochemistry revealed a coin-
cident fibrillar distribution of CCL21, suggesting these reticular 
fibers may represent rich regions of haptotactic guidance through 
immobilization of chemokines. As with infection in other sites, 
infection-induced focal chemokine production likely dictates T 
cell positioning in the CNS. West Nile virus-infected neurons 
produced CXCL10, which mediated CD8+ T cell parenchymal 
infiltration, specifically into the cerebellum (121). Intriguingly, 
CXCR3/CXCL10 deficiency affected parenchymal, but not 
perivascular T cell numbers, suggesting a differential requirement 
for this chemokine in recruitment to the CNS versus localization 
deeper within the tissue.
In non-infectious models of autoimmune inflammation in 
the brain, location-specific expression of individual chemokines 
appears to direct preferential CNS recruitment or retention 
of functionally distinct CD4 effector T cell subsets (122). Th1 
effectors mediated inflammation of the parenchyma of the spinal 
cord, but not the brain, while Th17 effectors supported extensive 
parenchymal inflammation in the brain, but not the spinal cord 
(123–125). Not surprisingly, such differences in positioning 
result in distinct neurological pathologies (122). The mecha-
nisms behind this phenomenon are incompletely understood. 
Differential entry sites into the CNS likely contribute to location 
specificity. Expression of CCL20 (a CCR6 ligand) by epithelial 
cells of the choroid plexus appear to promote CCR6-regulated 
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entry of Th17 cells (126). Whether anatomical differences in the 
tissue structure or ECM composition at these locations impacts 
the efficiency of Th1 or Th17 migration is not yet clear. However, a 
recent study has revealed that Th17 cells in the CNS have elevated 
expression of the integrin αVβ3 (56). Expression of αVβ3 appears 
to facilitate integrin:ECM-driven Th17 accumulation and func-
tion in the CNS as blockade of αVβ3 binding ameliorated Th17-
mediated EAE. Intravital imaging of Th1 and Th17 motility in the 
CNS will be important to determine whether they differentially 
utilize the inflammation-induced reticular fibers as guides for 
haptotactic interstitial migration and/or positional guidance.
FUTURe DiReCTiONS
Intravital imaging has only just begun to reveal the dynamic 
spatiotemporal control of immune function in inflamed tissues. 
Nonetheless, it has already provided novel insight into T cell inter-
actions with the surrounding tissue and with other leukocytes. 
Future identification of critical, context-dependent, molecular 
regulators of cellular migration will play an important role in the 
development of targeted therapeutics that attenuate leukocyte 
function in specific immune-mediated disease. The success 
of these efforts will depend on the ability to understand tissue 
signals in a combinatorial fashion. This will require visualizing 
the tissue topography at the level of ECM, immobilized chemical 
signals, and cellular heterogeneity as well as understanding how 
immune cells integrate and act on the complexity of such signals 
emanating from their inflamed surroundings.
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